PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23116186-0	2012	Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).	Pyrazinamide	27-46	diacylglycerol O-acyltransferase 1	Homo sapiens	67-99	
23116186-0	2012	Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).	Pyrazinamide	27-46	diacylglycerol O-acyltransferase 1	Homo sapiens	101-106	
23116186-1	2012	A new series of pyrazinecarboxamide DGAT1 inhibitors was designed to address the need for a candidate drug with good potency, selectivity, and physical and DMPK properties combined with a low predicted dose in man.	Pyrazinamide	16-35	diacylglycerol O-acyltransferase 1	Homo sapiens	36-41